Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020

SELL
$2.2 - $3.71 $25,440 - $42,902
-11,564 Closed
0 $0
Q2 2019

Aug 12, 2019

BUY
$3.98 - $6.2 $6,208 - $9,672
1,560 Added 15.59%
11,564 $67,000
Q1 2019

May 16, 2019

SELL
$2.0 - $4.4 $5,000 - $11,000
-2,500 Reduced 19.99%
10,004 $39,000
Q4 2018

Feb 15, 2019

BUY
$1.61 - $3.62 $20,131 - $45,264
12,504 New
12,504 $23,000
Q2 2018

Aug 13, 2018

SELL
$3.02 - $4.94 $15,100 - $24,700
-5,000 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$4.0 - $6.54 $20,000 - $32,700
5,000
5,000 $21,000

Others Institutions Holding TCRT

About Alaunos Therapeutics, Inc.


  • Ticker TCRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,182,000
  • Market Cap $424M
  • Description
  • Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...
More about TCRT
Track This Portfolio

Track Iht Wealth Management, LLC Portfolio

Follow Iht Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Iht Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Iht Wealth Management, LLC with notifications on news.